Evaluation of diagnostic and treatment approaches to acute dyspnea in a palliative care setting among medical doctors with different educational levels.
Klaus HacknerMagdalena HeimEva Katharina MaselGunther RiedlMichael WeberMatthäus StriederSandra DanningerMartin PecherstorferGudrun KreyePublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
The gold standard treatment for treating refractory dyspnea in patients with advanced lung cancer is opioids. Nevertheless, this pharmacological treatment option was not ranked as the most important. Discussing hypothetical cases of patients with advanced lung cancer and refractory dyspnea with experienced doctors as well as doctors at the beginning of their training may help improve symptom control for these patients.